Tuberous Sclerosis Complex (TSC): Multi-System Tumor Growth

Tuberous Sclerosis Complex (TSC) is a rare multi-system genetic disorder that triggers the growth of non-cancerous (benign) tumors, called hamartomas, in various vital organs. While these tumors are not typically cancerous, their growth can interfere with the function of the organ they occupy.

Common Symptoms by Organ System

Because TSC can affect almost any part of the body, symptoms are highly diverse and depend on tumor location:

Brain: Often leads to seizures (the most common symptom), intellectual disabilities, developmental delays, and behavioral issues like autism or ADHD.
Skin: Distinctive signs include ash-leaf spots (light-colored patches), angiofibromas (small reddish bumps on the face), and thickened, “shagreen” patches of skin.
Kidneys: Tumors (angiomyolipomas) can grow and affect kidney function or cause internal bleeding.
Heart: Tumors (rhabdomyomas) often appear at birth or in infancy but frequently shrink as the child grows.
Eyes and Lungs: White patches on the retina or lung lesions (especially in women) may occur.

Genetic Causes

TSC is caused by mutations in one of two genes: TSC1 (which produces the protein hamartin) or TSC2 (which produces tuberin). These proteins normally act as “brakes” to regulate cell growth. When they are faulty, cells grow uncontrollably, forming tumors.

Inheritance: About one-third of cases are inherited from a parent in an autosomal dominant pattern.
Spontaneous Mutation: Roughly two-thirds of cases result from a random, new mutation during early development (no family history).

Diagnosis and Management

Diagnosis is typically made through physical exams (checking skin and eyes) and imaging like MRI, CT scans, or Ultrasounds to locate internal tumors. Genetic testing can confirm the mutation.

mTOR Inhibitors: A significant breakthrough in treatment involves drugs like everolimus, which target the overactive growth pathway in TSC to shrink tumors and reduce seizures.
Seizure Management: Anti-epileptic drugs or, in some cases, surgery to remove the brain lesion causing the seizures.
Supportive Care: Early intervention through educational and occupational therapy is crucial for managing developmental and intellectual disabilities.
Ongoing Monitoring: Patients require lifelong “surveillance” with regular scans to ensure new tumors aren’t causing life-threatening complications in the kidneys, heart, or lungs.